Nanobiotix S.A. (NBTX)

NASDAQ: NBTX · IEX Real-Time Price · USD
8.98
-0.03 (-0.33%)
At close: Jan 19, 2022 4:00 PM
8.29
-0.69 (-7.68%)
After-hours:Jan 21, 2022 4:00 PM EST

Income Statement (Annual)

Millions EUR. Fiscal year is Jan - Dec.
Year202020192018
Revenue
2.512.543.48
Revenue Growth (YoY)
-1.14%-26.96%-
Gross Profit
2.512.543.48
Selling, General & Admin
14.6118.9112.65
Research & Development
24.3330.4120.89
Operating Expenses
38.9449.3233.55
Operating Income
-36.43-46.78-30.07
Interest Expense / Income
-2.654.971.45
Other Expense / Income
-0.2-0.84-1.17
Pretax Income
-33.58-50.91-30.35
Income Tax
0.0100
Net Income
-33.59-50.92-30.35
Net Income Common
-33.59-50.92-30.35
Shares Outstanding (Basic)
3333-
EPS (Basic)
-1.38-2.35-1.55
EPS (Diluted)
-1.38-2.35-1.55
Free Cash Flow Per Share
-0.85-1.31-
Gross Margin
100.00%100.00%100.00%
Operating Margin
-1450.20%-1840.97%-864.24%
Profit Margin
-1337.18%-2003.74%-872.23%
Free Cash Flow Margin
-1100.52%-1677.02%-761.45%
Effective Tax Rate
-0.03%-0.01%0.00%
EBITDA
-34.47-44.18-28.28
EBITDA Margin
-1372.33%-1738.49%-812.79%
EBIT
-36.23-45.94-28.9
EBIT Margin
-1442.16%-1808.03%-830.58%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).